Shattuck Labs, Inc.

NASDAQ:STTK

Biotechnology

Healthcare
$4.55 +2.33%

+$0.11 today

Market cap
$463.38M
Beta
1.09
P/E (TTM)
-10.9
EPS (TTM)
-$0.44
52W Low $0.71High $8.33

Volume 1.39M

Average 0.69M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$39.88M

FY 2025 · Annual

Investing Cash Flow

-$7.89M

FY 2025 · Annual

Financing Cash Flow

$44.57M

FY 2025 · Annual

+5563.8% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(44.97M)(101.95M)(87.3M)(75.41M)(48.81M)
Depreciation & Amortization1.38M3.07M4.04M3.83M3.69M
Deferred Income Tax3.04M0000
Stock-Based Compensation5.47M6.46M6.94M9.55M7M
Change in Working Capital(23.55M)(4.46M)(4.1M)3.02M(785K)
Accounts Receivables00000
Inventory00000
Accounts Payables7.87M(2.84M)(5.63M)832K(318K)
Other Working Capital(31.41M)(1.62M)1.53M2.19M(467K)
Other Non-Cash Items1.52M2.38M(816K)(1.5M)(971K)
Operating Cash Flow(57.12M)(94.5M)(81.23M)(60.52M)(39.88M)
Capital Expenditures(7.93M)(11.61M)(407K)(59K)(71K)
Acquisitions (Net)2.52M104K000
Purchases of Investments(204.09M)(132.38M)(79.73M)(93.55M)(43.42M)
Sales of Investments201.58M193.33M191M85.1M35.6M
Other Investing Activities(2.52M)0000
Investing Cash Flow(10.44M)49.44M110.86M(8.51M)(7.89M)
Debt Repayment00000
Common Stock Issued1.93M171K48.67M(17K)44.48M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00(53K)804K(65K)
Financing Cash Flow1.93M171K48.62M787K44.57M
Effect of Forex Changes00000
Net Change in Cash(65.63M)(44.89M)78.25M(68.24M)(3.2M)
Free Cash Flow(65.04M)(106.11M)(81.64M)(60.57M)(39.95M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$48.8M
+ D&A$3.7M
+ Stock-Based Comp$7.0M
+ Deferred Tax$0
- Working Capital-$785.0K
- Other Non-Cash-$971.0K
= Operating Cash Flow-$39.9M
- Capex-$71.0K
= Free Cash Flow-$40.0M

Analysis

FY2025 free cash flow is -$40.0M. FCF conversion is 81.9% of net income. Operating cash flow was -$39.9M, with capex of -$71.0K. The largest bridge item is Stock-Based Comp at $7.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
SC 13GSC 13G filingOct 27, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
10-QQuarterly reportAug 11, 2026

Does STTK generate free cash flow?

Shattuck Labs, Inc. (STTK) generated -$39.95M of free cash flow in fiscal 2025.

How much operating cash flow does STTK produce?

Operating cash flow was -$39.88M, before capital expenditures of $71,000.00.